News & Updates

Treatment with olezarsen in patients with hypertriglyceridemia and elevated cardiovascular risk results in substantial reductions in triglyceride, apolipoprotein B, and non–high-density lipoprotein cholesterol levels, while having no major safety signals, according to data from the phase IIb Bridge–TIMI 73a study.

Ablating the gastric fundus to reduce the production of the hunger hormone ghrelin helps women curb their appetite and lose body weight in the ABLATE-WEIGHT first-in-human trial.

Glucose-lowering drugs such as the glucagon-like peptide-1 receptor agonist (GLP-1-RA), sodium-glucose cotransporter 2 inhibitor (SGLT2i), and dipeptidyl peptidase-4 inhibitor (DPP-4i) work better and are more cost-effective than sulfonylureas and glinides (SU) as second-line treatment for type 2 diabetes (T2D), according to a population-based retrospective cohort study.

Women with lipedema who lose weight through proper diet can see improvements in their quality of life (QoL), suggests a study. Specifically, an energy-restricted low-carbohydrate diet (LCD) appears to be better at pain reduction than a standard control diet.

The American College of Cardiology and the American Heart Association (ACC/AHA), in collaboration with nine other societies, have released the 2024 guideline for managing peripheral artery disease (PAD), with new recommendations to guide practice.

A low-glycaemic index (GI) diet, based on a Mediterranean dietary (MedDiet) pattern, provides no substantial impact on major cardiometabolic risk factors at fasting in individuals at high cardiometabolic risk when compared with a high-GI MedDiet, a study has shown.

In adults with alcohol use disorder (AUD), high progesterone-to-estradiol ratios appear protective against problematic alcohol consumption, as shown in a study. Additionally, women with AUD may derive benefits from treatments tailored to their menstrual cycle phase.